Elaine Gemmell

Clear Surgical Ltd. designs, develops and manufactures and wholesales disposable surgical instruments. Its products include Oplight and Cannulated Forceps. The company is headquartered in Larbert, the United Kingdom.

Scottish Futures Trust Ltd. operates as a trust. The non-profit company is based in Edinburgh, UK. The British company was founded in 2008. Peter Charles Maxwell Reekie has been the CEO of the company since 2017.

Infinion Biopharma Ltd. manufactures and sells pharmaceutical products. It is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. Infinion has set up a global network of subsidiaries and portfolio companies focused on edge technologies across the health care spectrum including: Process Technology, Biotechnology, Formuation Technology. The company was founded on January 16, 2018 and is headquartered in Ahmedabad, India.

Scottish Health Innovations Ltd. develops healthcare technology innovations. It solutions encompass project management, market research, funding source, intellectual property protection and regulatory consulting. The company was founded in 2002 and is headquartered in Clydebank, the United Kingdom.

Part of Galliford Try Holdings Plc, Scottish Futures Trust Investments Ltd. is a British company that provides venture and development capital services. The company is based in Edinburgh, UK and was founded in 2010.

Part of ICON plc, GMG BioBusiness Ltd. is a British company that provides a comprehensive range of regulatory and product development consulting services. The company is based in Cambridge, UK. The company was founded by Gerry McGettigan. GMG BioBusiness was acquired by PRA Health Sciences, Inc., part of ICON plc from July 01, 2021.

Biopta Ltd. provides biological research and human tissues in drug development. It conducts research on the effect of drug activity prior to clinical trials using fresh human tissues. The firm engages in the use of functional human tissue to predict drug activity prior to clinical trials. It provides lab services, comparative pharmacology, clinical biopsies, in vitro and ex vivo techniques, and customized services, as well as cardiac, vascular, respiratory, gastrointestinal, human absorption, skin, and genitourinary related services. The company was founded by David Bunton and Chris Hillier and in 2002 and is headquartered in Glasgow, the United Kingdom.

Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom.

CardioPrecision Ltd. develops medical devices designed for minimally invasive cardiovascular surgery. The company is headquartered in Glasgow, the United Kingdom.